A New Jersey-based healthcare company turned heads on Tuesday following HC Wainwright & Co. maintaining a buy rating while raising its price target from $7 to $10/share. This...

To read the full story on AllPennyStocks.com, click here.

Protalix BioTherapeutics (AMEX:PLX)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025 Click aqui para mais gráficos Protalix BioTherapeutics.
Protalix BioTherapeutics (AMEX:PLX)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025 Click aqui para mais gráficos Protalix BioTherapeutics.